Market Cap 3.34M
Revenue (ttm) 5.05M
Net Income (ttm) -7.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -139.41%
Debt to Equity Ratio 0.00
Volume 10,569
Avg Vol 22,590
Day's Range N/A - N/A
Shares Out 1.37M
Stochastic %K 69%
Beta 0.57
Analysts Strong Buy
Price Target $12.00

Company Profile

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Industry: Packaged Foods
Sector: Consumer Defensive
Phone: 214 974 8921
Fax: 530 756 7027
Address:
5950 Sherry Lane, Suite 215, Dallas, United States
ArbitrageMoto
ArbitrageMoto Jan. 8 at 4:10 PM
$RKDA how come shorts didn’t push it below a $1?
1 · Reply
topstockalerts
topstockalerts Jan. 8 at 1:30 PM
$RKDA setting up nicely.. 🍾
0 · Reply
MElucky
MElucky Jan. 7 at 9:05 PM
$RKDA All time for RKDA ( incl 2 RS ) is $140+. It will proably go much higher with such a low float, and $ABVE price climbing up like a Madman. Hope Mgmt. of RKDA don't sell too fast.
2 · Reply
gametheory101
gametheory101 Jan. 4 at 10:49 AM
$ABVE $RKDA recd the 2.7m $ABVE shares in Jun2025 when it sold GoodWheat to ABVE and elected to take ABVE stock under the $6M promissory note (stock election notice: May1 2025) under SEC Rule 144. R 144 prohibits the resale of these 2.7m restricted share until, among others, ➡️ 6-mth lockup -> ended in Dec2025 ➡️ ABVE is current in filings This means RKDA's 2.7m ABVE shares are currently restricted securities under R144 regulatory freeze, even as RKDA nears insolvency with just $1M cash left but $2.5m in operating expenses and just $1.3m revenues in q3 2025. So no matter how cash-strapped RKDA is right now, it CANNOT just dump the 2.7m ABVE share until ABVE files its 20f, by which time, ABVE shd be trading at a wholly diff level. Given RKDA's dire cash flow situation, it might hv to turn to massively dilutive ATM sh sale if ABVE still doesn't drop its 20f soon. Just imagine the immense pressure ABVE must be facing from RKDA as well to urgently file its 20f..
1 · Reply
MElucky
MElucky Jan. 2 at 7:59 PM
$RKDA Bought shares here because $RKDA owns 2.7 Million shares of $ABVE. When $ABVE start its explosion, $RKDA price will explode. And $RKDA only has 1.37 Million shares. That's very low float..
0 · Reply
ArbitrageMoto
ArbitrageMoto Jan. 2 at 12:23 AM
$RKDA volume is up as shorts are expecting it to go down to pennys. IMO shutdown news sometimes in 2026 followed by director and board being sued for mismanagement and bad judgement. Probably prior CEOs will get sued. LOL. Suggest don’t buy the short vol and you should have taken 2025 loss on this.
0 · Reply
JohnTrack
JohnTrack Dec. 29 at 10:10 PM
$RKDA Roosevelt terminating the Exchange Agreement, really bad news https://www.rapidticker.com/news/rkda-sec-filing-efd678
0 · Reply
ArbitrageMoto
ArbitrageMoto Dec. 29 at 9:11 PM
$RKDA this will be heading below $1 soon and watch for another reverse split. LOL.
0 · Reply
ArbitrageMoto
ArbitrageMoto Dec. 29 at 9:08 PM
$RKDA not sure what all this history implies? All warrants are out of the money and essentially have no intrinsic value. I would say dump it all. Let shorts close their position and wish them a happy new year.
0 · Reply
AllandaleCapital
AllandaleCapital Dec. 29 at 1:10 PM
$RKDA live short interest 2.84% , been on a nosedive towards 2.50 critical support Shares: 1.37M OS / 1.36M float Market Cap: ~$3.6M Cash: ~$4.6M (est.) Outstanding Warrants (active / relevant): • 666,334 @ $9.00 (Mar 2023 Series A) • 118,063 @ $9.00 (Aug 2022) • 666,334 @ $9.00 (Mar 2023 Series B — expired Sept 2024) • 65,466 @ $9.00 (Dec 2020) • 18,133 @ $9.00 (Sept 2019) Total meaningful warrants near current zone: ~868,000 warrants @ $9.00 strike High-strike legacy warrants (functionally irrelevant at current prices): • 98,460 @ $125.20 • 34,808 @ $191.00 • 16,035 @ $154.00 • 12,757 @ $200.00 • additional 2018–2020 issues above $400 Completed: (1)January 2021 RDO • Method: Registered Direct Offering (S-3) • Shares Issued: 7,876,784 @ $3.19 • Warrants: 3,938,392 (1:2 coverage) • Gross Proceeds: $25,146,633 • Banker: HC Wainwright • Buyer Base: 3i, Alpha Capital Anstalt, Alto, Anson, BPY, Boothbay, Brio, CVI, Cavalry, Empery, FiveT, Hamilton Stuart, Intracoastal, Iroquois, Kingsbrook, Lind Global, MMCAP, Nomis Bay, Sabby • Comment: foundational dilution event, reset the float and embedded years of overhang (2) December 2020 RDO • Method: Registered Direct (S-3) • Shares Issued: 2,618,658 @ $3.06 • Warrants: 2,618,658 (full coverage) • Gross: $8,000,000 • Banker: HC Wainwright • Buyer Base: Alpha Capital Anstalt, Armistice, Bigger Capital, Brio, Cavalry, District 2, FiveT, Intracoastal, Iroquois, L1 • Comment: dilution stack continuation, sets stage for further resets (3) September 2019 RDO • Method: Registered Direct (S-3) • Shares Issued: 1,489,575 @ $4.91 • Warrants: 1,489,575 • Gross: $7,313,813 • Banker: HC Wainwright • Buyer Base: Anson, Armistice, CVI, Hudson Bay, Intracoastal, Sabby • Comment: start of the multi-year recycle of the same investor cohort (4) August 2022 RDO • Method: Registered Direct (S-3) • Shares Issued: 4,722,506 @ $1.06 • Warrants: 4,722,506 • Gross: $5,005,856 • Banker: HC Wainwright • Buyer Base: Armistice • Comment: aggressive pricing reset; cost basis anchor for Armistice (5) March 2023 “Private Placement” • Method: PIPE (not ATM / not public book) • Shares: 666,334 @ $9.00 • Warrants: 1,332,668 (200% coverage) • Gross: $5,997,006 • Banker: HC Wainwright • Buyer Base: Armistice (concentrated) • Comment: primary reference price for today’s $9.00 warrant grid (6) IPO — November 2021 (context, not driving current structure) • Shares: 2,160,000 @ $10.00 • Warrants: 4,320,000 • Gross: $21,600,000 • Bankers: Dawson James, I-Bankers • Comment: initial capital raise but legacy now irrelevant for price context
0 · Reply
Latest News on RKDA
Arcadia Biosciences, Inc. (RKDA) Q1 2025 Earnings Call Transcript

May 11, 2025, 10:32 AM EDT - 8 months ago

Arcadia Biosciences, Inc. (RKDA) Q1 2025 Earnings Call Transcript


Arcadia Biosciences, Inc (RKDA) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 7:37 PM EDT - 10 months ago

Arcadia Biosciences, Inc (RKDA) Q4 2024 Earnings Call Transcript


Arcadia Biosciences (RKDA) Announces Leadership Transition

Jul 9, 2024, 8:02 AM EDT - 1 year ago

Arcadia Biosciences (RKDA) Announces Leadership Transition


Arcadia Biosciences (RKDA) Announces Strategic Review

Jul 20, 2023, 8:02 AM EDT - 2 years ago

Arcadia Biosciences (RKDA) Announces Strategic Review


ArbitrageMoto
ArbitrageMoto Jan. 8 at 4:10 PM
$RKDA how come shorts didn’t push it below a $1?
1 · Reply
topstockalerts
topstockalerts Jan. 8 at 1:30 PM
$RKDA setting up nicely.. 🍾
0 · Reply
MElucky
MElucky Jan. 7 at 9:05 PM
$RKDA All time for RKDA ( incl 2 RS ) is $140+. It will proably go much higher with such a low float, and $ABVE price climbing up like a Madman. Hope Mgmt. of RKDA don't sell too fast.
2 · Reply
gametheory101
gametheory101 Jan. 4 at 10:49 AM
$ABVE $RKDA recd the 2.7m $ABVE shares in Jun2025 when it sold GoodWheat to ABVE and elected to take ABVE stock under the $6M promissory note (stock election notice: May1 2025) under SEC Rule 144. R 144 prohibits the resale of these 2.7m restricted share until, among others, ➡️ 6-mth lockup -> ended in Dec2025 ➡️ ABVE is current in filings This means RKDA's 2.7m ABVE shares are currently restricted securities under R144 regulatory freeze, even as RKDA nears insolvency with just $1M cash left but $2.5m in operating expenses and just $1.3m revenues in q3 2025. So no matter how cash-strapped RKDA is right now, it CANNOT just dump the 2.7m ABVE share until ABVE files its 20f, by which time, ABVE shd be trading at a wholly diff level. Given RKDA's dire cash flow situation, it might hv to turn to massively dilutive ATM sh sale if ABVE still doesn't drop its 20f soon. Just imagine the immense pressure ABVE must be facing from RKDA as well to urgently file its 20f..
1 · Reply
MElucky
MElucky Jan. 2 at 7:59 PM
$RKDA Bought shares here because $RKDA owns 2.7 Million shares of $ABVE. When $ABVE start its explosion, $RKDA price will explode. And $RKDA only has 1.37 Million shares. That's very low float..
0 · Reply
ArbitrageMoto
ArbitrageMoto Jan. 2 at 12:23 AM
$RKDA volume is up as shorts are expecting it to go down to pennys. IMO shutdown news sometimes in 2026 followed by director and board being sued for mismanagement and bad judgement. Probably prior CEOs will get sued. LOL. Suggest don’t buy the short vol and you should have taken 2025 loss on this.
0 · Reply
JohnTrack
JohnTrack Dec. 29 at 10:10 PM
$RKDA Roosevelt terminating the Exchange Agreement, really bad news https://www.rapidticker.com/news/rkda-sec-filing-efd678
0 · Reply
ArbitrageMoto
ArbitrageMoto Dec. 29 at 9:11 PM
$RKDA this will be heading below $1 soon and watch for another reverse split. LOL.
0 · Reply
ArbitrageMoto
ArbitrageMoto Dec. 29 at 9:08 PM
$RKDA not sure what all this history implies? All warrants are out of the money and essentially have no intrinsic value. I would say dump it all. Let shorts close their position and wish them a happy new year.
0 · Reply
AllandaleCapital
AllandaleCapital Dec. 29 at 1:10 PM
$RKDA live short interest 2.84% , been on a nosedive towards 2.50 critical support Shares: 1.37M OS / 1.36M float Market Cap: ~$3.6M Cash: ~$4.6M (est.) Outstanding Warrants (active / relevant): • 666,334 @ $9.00 (Mar 2023 Series A) • 118,063 @ $9.00 (Aug 2022) • 666,334 @ $9.00 (Mar 2023 Series B — expired Sept 2024) • 65,466 @ $9.00 (Dec 2020) • 18,133 @ $9.00 (Sept 2019) Total meaningful warrants near current zone: ~868,000 warrants @ $9.00 strike High-strike legacy warrants (functionally irrelevant at current prices): • 98,460 @ $125.20 • 34,808 @ $191.00 • 16,035 @ $154.00 • 12,757 @ $200.00 • additional 2018–2020 issues above $400 Completed: (1)January 2021 RDO • Method: Registered Direct Offering (S-3) • Shares Issued: 7,876,784 @ $3.19 • Warrants: 3,938,392 (1:2 coverage) • Gross Proceeds: $25,146,633 • Banker: HC Wainwright • Buyer Base: 3i, Alpha Capital Anstalt, Alto, Anson, BPY, Boothbay, Brio, CVI, Cavalry, Empery, FiveT, Hamilton Stuart, Intracoastal, Iroquois, Kingsbrook, Lind Global, MMCAP, Nomis Bay, Sabby • Comment: foundational dilution event, reset the float and embedded years of overhang (2) December 2020 RDO • Method: Registered Direct (S-3) • Shares Issued: 2,618,658 @ $3.06 • Warrants: 2,618,658 (full coverage) • Gross: $8,000,000 • Banker: HC Wainwright • Buyer Base: Alpha Capital Anstalt, Armistice, Bigger Capital, Brio, Cavalry, District 2, FiveT, Intracoastal, Iroquois, L1 • Comment: dilution stack continuation, sets stage for further resets (3) September 2019 RDO • Method: Registered Direct (S-3) • Shares Issued: 1,489,575 @ $4.91 • Warrants: 1,489,575 • Gross: $7,313,813 • Banker: HC Wainwright • Buyer Base: Anson, Armistice, CVI, Hudson Bay, Intracoastal, Sabby • Comment: start of the multi-year recycle of the same investor cohort (4) August 2022 RDO • Method: Registered Direct (S-3) • Shares Issued: 4,722,506 @ $1.06 • Warrants: 4,722,506 • Gross: $5,005,856 • Banker: HC Wainwright • Buyer Base: Armistice • Comment: aggressive pricing reset; cost basis anchor for Armistice (5) March 2023 “Private Placement” • Method: PIPE (not ATM / not public book) • Shares: 666,334 @ $9.00 • Warrants: 1,332,668 (200% coverage) • Gross: $5,997,006 • Banker: HC Wainwright • Buyer Base: Armistice (concentrated) • Comment: primary reference price for today’s $9.00 warrant grid (6) IPO — November 2021 (context, not driving current structure) • Shares: 2,160,000 @ $10.00 • Warrants: 4,320,000 • Gross: $21,600,000 • Bankers: Dawson James, I-Bankers • Comment: initial capital raise but legacy now irrelevant for price context
0 · Reply
ArbitrageMoto
ArbitrageMoto Dec. 28 at 1:00 PM
$RKDA guessing it is off due to suppressed oil prices.
2 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 26 at 4:56 PM
0 · Reply
Sylov
Sylov Dec. 26 at 4:17 PM
$RKDA merger broke. Now we have a valuation of 3.6M, with 5m in cash and 4.6m in current value of ABVE shares with 800k more shares owed. Not the outcome id hoped for but this seems even more undervalued here given pure asset value
3 · Reply
mikesterz7
mikesterz7 Dec. 26 at 4:11 PM
$RKDA Arcadia and Roosevelt had entered into a business combination agreement in December 2024 in the form of an all-stock transaction.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 26 at 4:01 PM
$RKDA RSI: 22.75, MACD: -0.1627 Vol: 0.29, MA20: 3.58, MA50: 3.76 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
JohnTrack
JohnTrack Dec. 26 at 2:49 PM
$RKDA no rush, just observing...
0 · Reply
Arce75
Arce75 Dec. 26 at 2:37 PM
$RKDA enough shit, i’m out
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 26 at 2:12 PM
RKDA Stock Rises Pre-Market After Company Receives Merger Termination Notice From Roosevelt Resources $RKDA https://stocktwits.com/news/equity/markets/rkda-stock-rises-pre-market-merger-termination-notice-roosevelt/cLeU9qYREwr
0 · Reply
LandonCapital
LandonCapital Dec. 26 at 2:11 PM
$RKDA https://landoncapital.net/the-deal-is-off-roosevelt-terminates-merger-deal-with-arcadia-biosciences-nasdaq-rkda/
0 · Reply
JohnTrack
JohnTrack Dec. 26 at 1:22 PM
$RKDA Termination Notice of the Proposed Business Combination, bad news... https://www.rapidticker.com/news/rkda-arcadia-biosciences-rkda-receives-termination-eeffee
0 · Reply
greatwhale
greatwhale Dec. 18 at 2:32 AM
$RKDA The Arcadia Biosciences (RKDA) annual stockholder meeting is scheduled for December 19, 2025, which is in three days (as of December 16, 2025). This meeting includes a vote on matters related to the proposed exchange agreement with Roosevelt Resources, LP, which is the transaction presumably referred to as a "merger". The acquisition is still proceeding as planned, subject to stockholder approval and other customary closing conditions.
1 · Reply
sarahrah
sarahrah Dec. 10 at 6:56 PM
$RKDA annual shareholder meeting on December 19th. Any chance of announcing an actual merger date? https://finance.yahoo.com/sec-filing/RKDA/0001193125-25-288164_1469443/
6 · Reply